359 related articles for article (PubMed ID: 36111299)
21. Measurement of β-Arrestin Recruitment at GPCRs Using the Tango Assay.
Laroche G; Giguère PM
Methods Mol Biol; 2019; 1947():257-267. PubMed ID: 30969421
[TBL] [Abstract][Full Text] [Related]
22. Contribution of heteromerization to G protein-coupled receptor function.
Gaitonde SA; González-Maeso J
Curr Opin Pharmacol; 2017 Feb; 32():23-31. PubMed ID: 27835800
[TBL] [Abstract][Full Text] [Related]
23. Exploring the signaling space of a GPCR using bivalent ligands with a rigid oligoproline backbone.
Romantini N; Alam S; Dobitz S; Spillmann M; De Foresta M; Schibli R; Schertler GFX; Wennemers H; Deupi X; Behe M; Berger P
Proc Natl Acad Sci U S A; 2021 Nov; 118(48):. PubMed ID: 34810259
[TBL] [Abstract][Full Text] [Related]
24. Arrestin-Dependent and -Independent Internalization of G Protein-Coupled Receptors: Methods, Mechanisms, and Implications on Cell Signaling.
Moo EV; van Senten JR; Bräuner-Osborne H; Møller TC
Mol Pharmacol; 2021 Apr; 99(4):242-255. PubMed ID: 33472843
[TBL] [Abstract][Full Text] [Related]
25. Moonlighting characteristics of G protein-coupled receptors: focus on receptor heteromers and relevance for neurodegeneration.
Borroto-Escuela DO; Tarakanov AO; Guidolin D; Ciruela F; Agnati LF; Fuxe K
IUBMB Life; 2011 Jul; 63(7):463-72. PubMed ID: 21698749
[TBL] [Abstract][Full Text] [Related]
26. Terminating G-Protein Coupling: Structural Snapshots of GPCR-β-Arrestin Complexes.
Chaturvedi M; Maharana J; Shukla AK
Cell; 2020 Mar; 180(6):1041-1043. PubMed ID: 32169216
[TBL] [Abstract][Full Text] [Related]
27. Elucidating structural and molecular mechanisms of β-arrestin-biased agonism at GPCRs via MS-based proteomics.
Xiao K; Sun J
Cell Signal; 2018 Jan; 41():56-64. PubMed ID: 28939107
[TBL] [Abstract][Full Text] [Related]
28. Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes.
Smith NJ; Milligan G
Pharmacol Rev; 2010 Dec; 62(4):701-25. PubMed ID: 21079041
[TBL] [Abstract][Full Text] [Related]
29. Biased signalling: the instinctive skill of the cell in the selection of appropriate signalling pathways.
Liu Y; Yang Y; Ward R; An S; Guo XX; Li W; Xu TR
Biochem J; 2015 Sep; 470(2):155-67. PubMed ID: 26348905
[TBL] [Abstract][Full Text] [Related]
30. History and biological significance of GPCR heteromerization in the neuroendocrine system.
Tadagaki K; Jockers R; Kamal M
Neuroendocrinology; 2012; 95(3):223-31. PubMed ID: 22156565
[TBL] [Abstract][Full Text] [Related]
31. G-Protein/β-Arrestin-Linked Fluctuating Network of G-Protein-Coupled Receptors for Predicting Drug Efficacy and Bias Using Short-Term Molecular Dynamics Simulation.
Ichikawa O; Fujimoto K; Yamada A; Okazaki S; Yamazaki K
PLoS One; 2016; 11(5):e0155816. PubMed ID: 27187591
[TBL] [Abstract][Full Text] [Related]
32. Methods to Monitor the Trafficking of β-Arrestin/G Protein-Coupled Receptor Complexes Using Enhanced Bystander BRET.
Cao Y; Namkung Y; Laporte SA
Methods Mol Biol; 2019; 1957():59-68. PubMed ID: 30919346
[TBL] [Abstract][Full Text] [Related]
33. Role of β-arrestins and arrestin domain-containing proteins in G protein-coupled receptor trafficking.
Kang DS; Tian X; Benovic JL
Curr Opin Cell Biol; 2014 Apr; 27():63-71. PubMed ID: 24680432
[TBL] [Abstract][Full Text] [Related]
34. Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential.
Seyedabadi M; Ghahremani MH; Albert PR
Pharmacol Ther; 2019 Aug; 200():148-178. PubMed ID: 31075355
[TBL] [Abstract][Full Text] [Related]
35. G Protein-Coupled Receptor Signaling Through β-Arrestin-Dependent Mechanisms.
Jean-Charles PY; Kaur S; Shenoy SK
J Cardiovasc Pharmacol; 2017 Sep; 70(3):142-158. PubMed ID: 28328745
[TBL] [Abstract][Full Text] [Related]
36. Identification and profiling of CXCR3-CXCR4 chemokine receptor heteromer complexes.
Watts AO; van Lipzig MM; Jaeger WC; Seeber RM; van Zwam M; Vinet J; van der Lee MM; Siderius M; Zaman GJ; Boddeke HW; Smit MJ; Pfleger KD; Leurs R; Vischer HF
Br J Pharmacol; 2013 Apr; 168(7):1662-74. PubMed ID: 23170857
[TBL] [Abstract][Full Text] [Related]
37. Role of antibodies in developing drugs that target G-protein-coupled receptor dimers.
Hipser C; Bushlin I; Gupta A; Gomes I; Devi LA
Mt Sinai J Med; 2010; 77(4):374-80. PubMed ID: 20687183
[TBL] [Abstract][Full Text] [Related]
38. Functional competence of a partially engaged GPCR-β-arrestin complex.
Kumari P; Srivastava A; Banerjee R; Ghosh E; Gupta P; Ranjan R; Chen X; Gupta B; Gupta C; Jaiman D; Shukla AK
Nat Commun; 2016 Nov; 7():13416. PubMed ID: 27827372
[TBL] [Abstract][Full Text] [Related]
39. Serodolin, a β-arrestin-biased ligand of 5-HT
El Khamlichi C; Reverchon F; Hervouet-Coste N; Robin E; Chopin N; Deau E; Madouri F; Guimpied C; Colas C; Menuet A; Inoue A; Bojarski AJ; Guillaumet G; Suzenet F; Reiter E; Morisset-Lopez S
Proc Natl Acad Sci U S A; 2022 May; 119(21):e2118847119. PubMed ID: 35594393
[TBL] [Abstract][Full Text] [Related]
40. G Protein-Coupled Receptor Heteromers.
Gomes I; Ayoub MA; Fujita W; Jaeger WC; Pfleger KD; Devi LA
Annu Rev Pharmacol Toxicol; 2016; 56():403-25. PubMed ID: 26514203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
